ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

Por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado em 2014

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey

Por Banerjee, Susana, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Curigliano, Giuseppe, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Hofstädter-Thalmann, Eva, Robert, Caroline, Sessa, Cristiana, Tsourti, Zoi, Zygoura, Panagiota, Peters, Solange
Publicado no ESMO Open (2018)

PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer

Por Pereira, Stephen P, Jitlal, Mark, Duggan, Marian, Lawrie, Emma, Beare, Sandy, O’Donoghue, Pam, Wasan, Harpreet S, Valle, Juan W, Bridgewater, John
Publicado no ESMO Open (2018)

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy

Por Dolly, Saoirse O, Migali, Cristina, Tunariu, Nina, Della-Pepa, Chiara, Khakoo, Shelize, Hazell, Steve, de Bono, Johann S, Kaye, Stanley B, Banerjee, Susana
Publicado no ESMO Open (2017)

Interventions to improve care coordination between primary healthcare and oncology care providers: a systematic review

Por Tomasone, Jennifer R, Brouwers, Melissa C, Vukmirovic, Marija, Grunfeld, Eva, O'Brien, Mary Ann, Urquhart, Robin, Walker, Melanie, Webster, Fiona, Fitch, Margaret
Publicado no ESMO Open (2016)

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort

Por Bonneterre, Jacques, Bosq, Jacques, Jamme, Philippe, Valent, Alexander, Gilles, Erard M, Zukiwski, Alexander A, Fuqua, Suzanne A W, Lange, Carol A, O'Shaughnessy, Joyce
Publicado no ESMO Open (2016)

Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice

Por Sherwood, James L, Brown, Helen, Rettino, Alessandro, Schreieck, Amelie, Clark, Graeme, Claes, Bart, Agrawal, Bhuwnesh, Chaston, Ria, Kong, Benjamin S G, Choppa, Paul, Nygren, Anders O H, Deras, Ina L, Kohlmann, Alexander
Publicado no ESMO Open (2017)

Hallmarks of glioblastoma: a systematic review

Por Nørøxe, Dorte Schou, Poulsen, Hans Skovgaard, Lassen, Ulrik
Publicado no ESMO Open (2017)

Laparoscopic Wedge Resection of Gastric Stromal Tumor (GIST)

Por Samardzic, Josip, Hreckovski, Boris, Hasukic, Ismar, Hasukic, Sefik
Publicado no Med Arch (2015)

AB053. P-21. M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BT...

Por Yoo, Changhoon, Oh, Do-Youn, Choi, Hye Jin, Kudo, Masatoshi, Ueno, Makoto, Kondo, Shunsuke, Chen, Li-Tzong, Osada, Motonobu, Helwig, Christoph, Dussault, Isabelle, Ikeda, Masafumi
Publicado no Hepatobiliary Surg Nutr (2019)